Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The life-science company Polypeptide announced in January of 2025 that they will be employing about 100 new workers to meet the increased demand for their Peptide products, which are used in fat loss and diabetic pharmaceutical products. The company stated that the entire business of fat loss medication is in a boom period. The company is investing about 100 million euros as part of their efforts to double the production capacity at the factory located in Limhamn, just outside of the southern Swedish city of Malmö.
Polypeptide started as a company in Malmö and is now active in several countries in Europe, USA and India. The company employs about 1300 employees globally.
Eurofound (2025), Polypeptide, Business expansion in Sweden, factsheet number 202202, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/202202.